UK start-up Complement Therapeutics has raised an impressive €72 million ($79 million) in first-round financing that will be used to take a gene therapy for sight-robbing disease geographic atrophy ...

A Crew Dragon spacecraft docked with the International Space Station on Valentine’s Day, and astronauts popped open the hatches at 5:14 pm ET (22:14 UTC) on Saturday evening. The arrival of four new ...

Suchandrima Bhowmik has written over 300 articles on various health conditions, medical news, and recent breakthroughs. Her work appears in several publications, including Medical News Today, ...

Carrie Madormo, RN, MPH, is a health writer. She has over a decade of experience as a registered nurse, practicing in a variety of fields, such as pediatrics, oncology, chronic pain, and public health ...

The complement system is an innate immune response that leads to increased inflammation. The drug pegcetacoplan—a complement inhibitor—was approved for medical use in the United States in 2021 to ...

12:44, Thu, Nov 27, 2025 Updated: 12:49, Thu, Nov 27, 2025 This mysterious interstellar object has left experts baffled as they battle to work out what it is and where it’s come from. Roaring across ...

A happy couple who first met seven years ago when they both awoke from comas got engaged inside the same hospital where they were treated as teenagers. Zach Zarembinski popped the question to Isabelle ...

The Pac-12 has undergone as bigger shuffle than any other as the conference-realignment era of college athletics has shaken up countless programs around the country. Oregon State and Washington State ...

Among people with sickle cell disease—an inherited blood disorder—acute chest syndrome (ACS) is the leading cause of death. The condition is the result of red blood cells becoming stiff, sticky, and ...

ARO-C3 treatment led to deep and sustained reductions in alternative pathway complement activity and proteinuria. ARO-C3, an investigational RNA interference-based therapy targeting hepatic expression ...

Mirima Freimer, MD, delves into potential reasons behind the longer-term efficacy of zilucoplan and also speaks to the treatment’s safety profile. Freimer was an author on 5 abstracts presented at the ...

Suggested remit: To appraise the clinical and cost effectiveness of pegcetacoplan within its marketing authorisation for treating primary complement 3 (C3) glomerulopathy and primary immune-complex ...